S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

REPL Replimune Group Inc

13.78

-0.25 (-1.78%)

After Hours

Last Updated: 15:08:26

Delayed by 15 minutes

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Replimune (NASDAQ:REPL)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Replimune Charts.

Replimune (NASDAQ:REPL)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Replimune Charts.

Replimune Group Inc News

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 14 February 2025 (5 days ago) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Wednesday 12 February 2025 (1 week ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 12 February 2025 (1 week ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 12 February 2025 (1 week ago) • Edgar (US Regulatory)

Replimune Reports Fiscal Third Quarter 2025 Financial Results and Provides Corporate Update
Wednesday 12 February 2025 (1 week ago) • GlobeNewswire Inc.

Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Friday 7 February 2025 (2 weeks ago) • GlobeNewswire Inc.

Form 8-K - Current report
Wednesday 22 January 2025 (4 weeks ago) • Edgar (US Regulatory)

Replimune Announces Biologics License Application Acceptance and Priority Review for RP1 for the Treatment of Advanced Melanoma
Tuesday 21 January 2025 (4 weeks ago) • GlobeNewswire Inc.

Form S-8 - Securities to be offered to employees in employee benefit plans
Friday 17 January 2025 (1 month ago) • Edgar (US Regulatory)

Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Friday 10 January 2025 (1 month ago) • GlobeNewswire Inc.

Replimune Announces RP2 Development Program Advances with First Patients Enrolled in Metastatic Uveal Melanoma and Hepatocellular Carcinoma Clinical Trials
Wednesday 8 January 2025 (1 month ago) • GlobeNewswire Inc.

Replimune to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Monday 23 December 2024 (2 months ago) • GlobeNewswire Inc.

More Replimune Group Inc News Articles

Blue Hat Interactive Ent...

Mullen Automotive

Bell Buckle (PK)

Super Micro Computer

North Bay Resources (PK)

TPT Global Tech (PK)

Voip Pal Com (QB)

Bioelectronics (PK)

MineralRite (PK)

Kraig Biocraft Laborator... (QB)

Digital Brand Media and ... (PK)

NioCorp Developments

Intergrated Cannabis Sol... (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions